Investigating brain changes in patients with progressive apraxia of speech
Official title: Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Run by Mayo Clinic · NCT01818661 · Data updated 2026-11-12
This study is trying to see how changes in the brain affect speech difficulties over time in people with progressive apraxia of speech.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | July 1, 2018 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | November 12, 2025 |
| Trial ID | NCT01818661 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with neurodegenerative apraxia of speech at the Mayo Clinic.
✕Probably not a fit
Patients with speech and language deficits due to concurrent illnesses like traumatic brain injury or strokes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the relationship between structural and functional brain changes observed through imaging techniques and the progression of speech and language difficulties in patients diagnosed with neurodegenerative apraxia of speech (AOS). It focuses on understanding how AOS, often associated with non-fluent aphasia, manifests and evolves over time, potentially leading to cognitive impairments. The study will utilize AV-1451 as an intervention to assess these changes in a longitudinal manner, providing insights into the neurological underpinnings of the disorder.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for patients suffering from apraxia of speech and related conditions.
How similar studies have gone: While there is ongoing research in related areas, this specific approach focusing on the longitudinal imaging of AOS is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * We will study subjects that fulfill clinical inclusion criteria for neurodegenerative AOS that have been seen and diagnosed at Mayo Clinic Exclusion Criteria: * Subjects with concurrent illnesses that could account for speech and language deficits, such as traumatic brain injury, strokes or developmental syndromes will be excluded. * Women that are pregnant or post-partum and breast-feeding will be excluded. All women who can become pregnant must have a pregnancy test no more than 48 hours before the PET scan. * Subjects will also be excluded if MRI is contraindicated (metal in head, cardiac pace maker, e.t.c.), if there is severe claustrophobia, if there are conditions that may confound brain imaging studies (e.g. structural abnormalities, including subdural hematoma or intracranial neoplasm), or if they are medically unstable or are on medications that might affect brain structure or metabolism,(e.g. chemotherapy). * Subjects will also be excluded if they do not have an informant, or do not consent to research.
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Jennifer Whitwell, PhD — Mayo Clinic
- Study coordinator: Sarah Boland, CCRP
- Email: boland.sarah@mayo.edu
- Phone: 507-284-3863
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding two types of progressive speech disorders
This study is trying to tell apart two types of speech disorders in people with progressive speech problems to better understand their causes and what they might mean for future health.
-
Stimulating the aging brain with brain and sensory stimulation for language), wait
This study tests whether transcranial alternating current stimulation (tACS) and multisensory stimulation can improve verbal short-term memory in people with Primary Progressive Aphasia.
-
Magnetic brain stimulation for frontotemporal lobar degeneration
This trial will try repetitive transcranial magnetic stimulation (rTMS) to see if it is safe and helps people with frontotemporal lobar degeneration or asymptomatic people at risk.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Investigating language development in children with communication challenges
This study is testing new ways to measure language growth in preschoolers with communication challenges, like Down Syndrome and Cerebral Palsy, to see what helps them learn to talk better.
-
Educational support program for bilingual individuals with progressive aphasia and their caregivers
This study is testing a support program for bilingual people with progressive aphasia and their caregivers to see if it helps them communicate better and cope with the challenges of the condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.